{
  "id": 16467991,
  "title": "Best Biotech Stocks Right Now",
  "url": "https://urgent.news/2026/10/25/best-biotech-stocks-right-now",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-25T11:12:39.000Z",
  "source": {
    "name": "Benzinga",
    "slug": "benzinga",
    "url": "https://www.benzinga.com/money/best-biotech-stocks"
  },
  "original_language": "en",
  "account": "Biotech stocks are gaining attention as the world continues to battle the COVID-19 pandemic. Investors are optimistic about biotech companies that develop vaccines and boosters for the virus. It is an opportune time to consider adding biotech stocks to one's portfolio for potential significant returns. Investors can find affordable options under $20 for daily trading on the stock market. Real-time gainers can be tracked with a free 14-day trial.\n\nBiotech stocks are a subset of healthcare stocks, with a primary focus on developing drugs and treatments for medical conditions and diseases, including viruses. The value of a biotech company's stock depends on the disease it targets and the success of its research efforts. For example, a biotech firm working on breast cancer treatments with nearly 300,000 new cases annually in the U.S. may be more valuable than a company developing drugs for a rare disease affecting only 1%-3% of the population.\n\nBefore a new drug developed by a biotech firm can be sold, it must undergo rigorous testing and receive approval from the Food and Drug Administration (FDA). Developing a new drug requires years of research and clinical trials, and not all drugs make it through this process. However, if a biotech company obtains FDA approval for a new drug with high demand, the stock value can experience a substantial increase. Online brokers can facilitate the trading of biotech stocks with advanced tools and real-time data, helping investors make informed decisions and potentially capitalize on market opportunities.",
  "summary": "The post Best Biotech Stocks Right Now by Chetan Shekar appeared first on Benzinga . Visit Benzinga to get more great content like this. Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a vaccine and boosters that can eradicate COVID-19. Tilt your stock…",
  "key_points": [
    "Biotech stocks gaining attention amid COVID-19 pandemic",
    "Affordable options under $20 for daily trading",
    "FDA approval crucial for substantial stock value increase"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}